Manual de Hipertensión Arterial en la Práctica Clínica de ... - SAMFyC

Manual de Hipertensión Arterial en la Práctica Clínica de Atención Primaria
Hipertensión en situaciones especiales
13. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major
cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA
2000;283:1967-75.
14. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering
regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet
2001;358:1033-41.
15. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al, for the LIFE study group.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in
hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
16. Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GLR, et al, for the Second Australian
National Blood Pressure Study Group. A comparison of outcomes with angiotensin-convertingenzyme
inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-92.
17. Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, et al. Morbidity and
Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention.
Principal Results of a Prospective Randomized Controlled Study (MOSES). Stroke 2005;36: 1218-
1226.
18. Staessen JA, Fagard R, Thijs L, Celis H, Araidze CG, Birkenhager Wh et al. Randomised doubleblind
comparison of placebo and active treatment for older patients with isolated systolic
hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;
350:757-764.
19. Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, et al. Antihypertensive drugs in
very old people: a subgroup analysis of randomised controlled trials. Lancet 1999; 353:793–796. MA
20. Messerli F, Grossman E Goldbourt U, Are β-Blockers Efficacious as First-line Therapy for
Hypertension in the Elderly? A Systematic Review JAMA 1998;279:1903-1907.
21. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment
of primary hypertension? A meta-analysis. Lancet 2005;366(9496):1545-53
22. Beevers DG. The end of beta blockers for uncomplicated hypertension? Lancet 2005;366:1510-1512
23. Marín R et al Hipertensión arterial en el embarazo: estudio de 864 casos consecutivos observados
durante un período de 24 años. Nefrologia 1999;19:308-317
24. Knight M, Duley L, Henderson-Smart DJ, King JF. Antiagregantes plaquetarios para la prevención y
el tratamiento de la preeclampsia. Revisión Cochrane traducida. En: La Biblioteca Cochrane Plus,
2005 número 2. Oxford:Update Software Ltd.
25. The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit
from magnesium sulphate? The Magpie Trial: randomized placebo-controlled trial. Lancet
2002;359:1877-90.
26. http://www.sld.cu/galerias/pdf/servicios/hta/guide_obstetric_of_hypertension_nov_2004.pdf
27. http://www.sld.cu/galerias/pdf/servicios/hta/guia_tratam_hiperten_embar_arg_.pdf
28. Hirsch et al. ACC/AHA Guidelines for the Management of Patients With Peripheral Arterial Disease
(Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). JACC 2006;20:1–75.
29. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at
risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
Grupo de Hipertensión Arterial
Sociedad Andaluza de Medicina de Familia
104